FDA: clinical language models

Chris von Csefalvay filed this request with the Food and Drug Administration of the United States of America.
Tracking #

FDA22088692

Est. Completion None
Status
Fix Required

Communications

From: Chris von Csefalvay

To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

Any document, e-mail, research or white paper that discusses whether CDER should or would or could exercise its enforcement powers in relation to any technology, software, application, platform or system that is, includes or utilises

1. natural language models
2. generative language models
3. chatbots
4. natural language processing
5. topic modeling
6. Latent Dirichlet Allocation

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Chris von Csefalvay

From: Food and Drug Administration

Please submit your request to our online FOIA request portal. See: FDA Freedom of Information Act (FOIA)<https://www.accessdata.fda.gov/scripts/foi/FOIRequest/index.cfm>.

Sarah B. Kotler, J.D.
Director, Division of Freedom of Information
US FDA
301-796-8976

From: Food and Drug Administration

*** This is an automated message. Please do not reply to this email. ***
Reference: FDA22088692
Dear Requester,
This is to confirm that you submitted a request for record(s) from the Food and Drug Administration
pursuant to the Freedom of Information Act.
FOIA staff will review your request to determine whether it has sufficient information to be processed;
if so, you will receive another email as a formal acknowledgement of your request, with a control number for your request.
If your request is not sufficiently described,
or if there are any other deficiencies with your submission, FOIA staff will contact you via telephone or email.

From: Food and Drug Administration

Control number: 2022-8961
Please find the attached acknowledgement regarding your FOIA request. Note: Do NOT reply directly to this E-mail

From: Food and Drug Administration

Good afternoon,

I am contacting you regarding the above referenced FOIA request. I would like to discuss the matter at your earliest convenience. Please contact me at 301-796-2660. Thank you.

Guruprasad Udapi
FOIA Branch Chief (CDER)
Work: (301) 796-2660
Cell: (240) 702-3926

Files

pages

Close